Delivering Influenza Vaccine to High-Risk Adults: Subspecialty Physician Practices

被引:8
|
作者
Jessop, Amy B. [1 ]
Dumas, Harry [2 ]
Moser, Charlotte A. [3 ]
机构
[1] Univ Sci Philadelphia, Philadelphia, PA 19104 USA
[2] Univ Med & Dent New Jersey, Stratford, NJ USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
关键词
influenza; vaccination; subspecialty; public health; IMMUNIZATION PRACTICES ACIP; INCREASE INFLUENZA; ADVISORY-COMMITTEE; RECOMMENDATIONS; GENERALIST; PREVENTION; ATTITUDES; RATES;
D O I
10.1177/1062860612456236
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Influenza is responsible for significant morbidity and mortality in the United States. Despite long-standing national recommendations, only 47% of adults with a high-risk condition received the influenza vaccine in 2009-2010. Subspecialty practices provide a significant portion of ambulatory care visits for high-risk adults and understanding their role in the immunization infrastructure may increase immunization rates, decrease public health burden, and reduce influenza-associated disease. A cross-sectional survey of cardiology, pulmonology, and obstetrics/gynecology practices was conducted to assess influenza vaccination practices, plans, patient acceptance, frustrations, and reasons for not vaccinating. It was found that 51% of respondents planned to vaccinate patients. Plans differed significantly by practice type. Practices that do not vaccinate generally recommend vaccination and refer patients to public health clinics, primary care, and pharmacies. Administrative and patient-related barriers affected most practices, but practices that vaccinate were able to overcome these barriers. Improvements in vaccination may be addressed by adapting practice support services for subspecialty practices.
引用
收藏
页码:232 / 237
页数:6
相关论文
共 50 条
  • [41] Cost-Effectiveness of Stockpiling 23-Valent Pneumococcal Polysaccharide Vaccine to Prevent Secondary Pneumococcal Infections Among a High-Risk Population in the United States During an Influenza Pandemic
    Dhankhar, Praveen
    Grabenstein, John D.
    O'Brien, Megan A.
    Dasbach, Erik J.
    CLINICAL THERAPEUTICS, 2010, 32 (08) : 1501 - 1516
  • [42] Relative Effectiveness of the MF59-Adjuvanted Influenza Vaccine Versus High-Dose Influenza Vaccine in Older Adults With Influenza Risk Factors During the 2019-2020 US Influenza Season
    Imran, Mahrukh
    Mills, Carrie W.
    McDermott, Kimberly W.
    Dean, Alex
    Bogdanov, Alina
    McGovern, Ian
    Haag, Mendel D. M.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (08):
  • [43] Benefits of influenza vaccination among healthy and high-risk persons across the age spectrum
    Nichol, KL
    OPTIONS FOR THE CONTROL OF INFLUENZA V, 2004, 1263 : 48 - 50
  • [44] The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations
    Wiggins, Kristin B.
    Smith, Maria A.
    Schultz-Cherry, Stacey
    VIRUSES-BASEL, 2021, 13 (06):
  • [45] Biomarkers for high-risk influenza patients: what are the next steps?
    Tang, Benjamin M.
    Shojaei, Maryam
    Branley, James
    McLean, Anthony
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (03) : 205 - 206
  • [46] Influenza vaccination in children with high-risk chronic diseases YY
    Hatziagorou, Elpis
    Argyropoulou, Evangelia
    Soldatou, Alexandra
    Tsanakas, John
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [47] Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China
    Wendlandt, Rachael
    Cowling, B. J.
    Chen, Yuyun
    Havers, Fiona
    Shifflett, Pat
    Song, Ying
    Zhang, Ran
    Iuliano, Danielle
    Xu, Cuiling
    Yu, Hongie
    Zhang, Jun
    Zhang, Hongjun
    Tang, Fenyang
    Thompson, Mark
    VACCINE, 2018, 36 (19) : 2673 - 2682
  • [48] Reducing Hospital Capacity Needs for Seasonal Respiratory Infections: The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults
    Zeevat, Florian
    Wilschut, Jan C.
    Boersma, Cornelis
    Postma, Maarten J.
    VALUE IN HEALTH, 2023, 26 (04) : 461 - 464
  • [49] Tdap vaccine attitudes and utilization among pregnant women from a high-risk population
    Dempsey, Amanda F.
    Brewer, Sarah E.
    Sevick, Carter
    Pyrzanowski, Jennifer
    Mazzoni, Sara
    O'Leary, Sean T.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (04) : 872 - 878
  • [50] Clinical factors associated with hepatitis B screening and vaccination in high-risk adults
    Ayoola, Rotimi
    Larion, Sebastian
    Poppers, David M.
    Williams, Renee
    WORLD JOURNAL OF HEPATOLOGY, 2019, 11 (01) : 86 - 98